Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
Eligible age
60–90 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease. * Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatient setting? * Neurology Clinic will complete a 6-month post-hospitalization follow up with patients who have had the Quest AD-Detect Alzheimer's Disease blood test completed while they were inpatient to discuss the risk assessment portfolio
Sponsor: Covenant Health, US
You may qualify if…
- ✓ Ages 60 to 90 years old
- ✓ No prior diagnosis of dementia
- ✓ Currently hospitalized with cognitive diagnosis, including but no limited to; delirium, encephalopathy, etc. thought to be secondary to a toxic/metabolic state
You may not qualify if…
- ✕ Age under 60 years
- ✕ Prior diagnosis of dementing illness or other organic etiology to cognitive impairment
Where it's recruiting
Crossville · Harriman · Knoxville · Lenoir City …
Source: ClinicalTrials.gov · NCT07222280 · last updated 2025-10-29